Physician

Timothy Jay Orlowski, MD

According to 2025 Medicare claims, Timothy Orlowski, MD (NPI: 1053760215) practices micrographic dermatologic surgery in the Athens-Clarke County, GA market, with the plurality of this provider's patient population coming from Clarke, GA. This provider's primary affiliated billing organization is GEORGIA SKIN CANCER & AESTHEITIC DERMATOLOGY, LLC (NPI: 1205026168; TIN: 260566555) and primary practice location at 30677-7122.

Orlowski's data goes back to 2015 and runs through 2024. Part D data shows 376 prescription claims across 183 beneficiaries totaling $173,123 in drug costs, led by Tacrolimus (Tacrolimus). Open Payments data shows 10 records totaling $545. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

No connected Part B records

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	11	12	$127
2020	N/R	N/R	N/R
2021	113	244	$144,643
2022	204	549	$305,842
2023	179	478	$178,970
2024	183	376	$173,123

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

No connected Part B code-level records for 2024.

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Tacrolimus	Tacrolimus	12	325	$1,691
Gentamicin Sulfate	Gentamicin Sulfate	29	729	$1,166
Fluorouracil	Fluorouracil	11	367	$662
Ketoconazole	Ketoconazole	26	790	$519
Triamcinolone Acetonide	Triamcinolone Acetonide	33	924	$495

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	10	$545	PFIZER INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Timothy Jay Orlowski, MD?

Tedicare shows public-source Medicare data for Timothy Jay Orlowski, MD (NPI 1053760215), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Timothy Jay Orlowski, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Timothy Jay Orlowski, MD?

Timothy Jay Orlowski, MD is linked to GEORGIA SKIN CANCER & AESTHEITIC DERMATOLOGY, LLC (billing NPI 1205026168) in the available physician profile data.

Does Timothy Jay Orlowski, MD have Open Payments data?

Timothy Jay Orlowski, MD has 10 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.